We conduct Bioavailability and Bioequivalence studies in compliance with Good Clinical Practices (GCP) and Good Laboratory Practices (GLP). We have conducted more than 250+ BE studies and have about 3000+ volunteers database. We provide several biovailability/bioequivelence studies, which include:

• Pilot and pivotal bioequivalence study
• Single dose and multiple dose study
• Fasting and fed condition
• Partially and fully replicate design
• Crossover and parallel design
• Comparative BA studies for different dosage forms
• Special population BA/BE studies.